MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pros.24058

Медицинская библиотека · The Prostate · 2020

Validation of a prostate cancer polygenic risk score.

Black Mary H, Li Shuwei, LaDuca Holly, Lo Min-Tzu, Chen Jefferey, Hoiness Robert, Gutierrez Stephanie, Tippin-Davis Brigette, Lu Hsiao-Mei, Gielzak Marta, Wiley Kathleen, Shi Zhuqing, Wei Jun, Zheng Siqun Lilly, Helfand Brian T, Isaacs William, Xu Jianfeng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Genome-wide association studies have identified over 100 single-nucleotide polymorphisms (SNPs) associated with prostate cancer (PrCa), and polygenic risk scores (PRS) based on their combined genotypes have been developed for risk stratification. We aimed to assess the contribution of PRS to PrCa risk in a large multisite study.

METHODS

The sample included 1972 PrCa cases and 1919 unaffected controls. Next-generation sequencing was used to assess pathogenic variants in 14 PrCa-susceptibility genes and 72 validated PrCa-associated SNPs. We constructed a population-standardized PRS and tested its association with PrCa using logistic regression adjusted for age and family history of PrCa.

RESULTS

The mean age of PrCa cases at diagnosis and age of controls at testing/last clinic visit was 59.5 ± 7.2 and 57.2 ± 13.0 years, respectively. Among 1740 cases with pathology data, 57.4% had Gleason score ≤ 6, while 42.6% had Gleason score ≥ 8. In addition, 39.6% cases and 20.1% controls had a family history of PrCa. The PRS was significantly higher in cases than controls (mean ± SD: 1.42 ± 1.11 vs 1.02 ± 0.76; P < .0001). Compared with men in the 1st quartile of age-adjusted PRS, those in the 2nd, 3rd, and 4th quartile were 1.58 (95% confidence interval [CI]: 1.31-1.90), 2.36 (95% CI: 1.96-2.84), and 3.98 (95% CI: 3.29-4.82) times as likely to have PrCa (all P < .0001). Adjustment for family history yielded similar results. PRS predictive performance was consistent with prior literature (area under the receiver operating curve = 0.64; 95% CI: 0.62-0.66).

CONCLUSIONS

These data suggest that a 72-SNP PRS is predictive of PrCa, supporting its potential use in clinical risk assessment.

Для цитирования: Black Mary H, Li Shuwei, LaDuca Holly, Lo Min-Tzu, Chen Jefferey, Hoiness Robert, Gutierrez Stephanie, Tippin-Davis Brigette, Lu Hsiao-Mei, Gielzak Marta, Wiley Kathleen, Shi Zhuqing, Wei Jun, Zheng Siqun Lilly, Helfand Brian T, Isaacs William, Xu Jianfeng. Validation of a prostate cancer polygenic risk score.. The Prostate. 2020. DOI: 10.1002/pros.24058.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.